Table 4.
Parameter | Estimate | Standard Error | 95% Confidence Intervals | P-value | ||
---|---|---|---|---|---|---|
WOMAC pain at 2 years | ||||||
SLE vs. OA | 3.95 | 3.28 | −2.47 | 10.4 | 0.23 | |
WOMAC Pain at Baseline | 0.14 | 0.09 | −0.04 | 0.32 | 0.12 | |
PCS at Baseline | 0.46 | 0.22 | 0.03 | 0.90 | 0.04 | |
MCS at Baseline | 0.24 | 0.11 | 0.02 | 0.46 | 0.03 | |
WOMAC Function at 2 years | ||||||
SLE vs. OA | 2.66 | 3.85 | −4.90 | 10.2 | 0.49 | |
WOMAC Function at Baseline | 0.32 | 0.11 | 0.10 | 0.54 | 0.01 | |
PCS at Baseline | 0.15 | 0.31 | −0.45 | 0.75 | 0.62 | |
MCS at Baseline | 0.35 | 0.13 | 0.10 | 0.60 | 0.01 |
Multivariate linear regression controlling for diagnosis, baseline WOMAC pain and function, and baseline MCS and PCS.
Bolding indicates a statistically significant value.